BMC Cancer

official impact factor 3.15

Open Access Highly Access

Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study

Ivette F Emery*, Chiara Battelli, Paul L Auclair, Kathleen Carrier and Daniel M Hayes

BMC Cancer 2009, 9:333 doi:10.1186/1471-2407-9-333

Accesses  

  • Last 30 days: 45 accesses
  • Last 365 days: 626 accesses
  • All time: 3472 accesses